Screener
Pulse Biosciences, Inc. PLSE Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $161K— | $31K— | $0— | -$193K— | $0— | ||
| $8.46M+3.3% | $6.59M-14.7% | $7.33M-23.6% | $8.78M+47.5% | $8.19M— | ||
| -$24.66M-28.6% | -$18.58M-10.6% | -$17.43M+10.1% | -$19.39M-52.9% | -$19.17M-68.4% | ||
| -$25.02M-25.0% | -$18.9M-6.4% | -$17.99M+9.9% | -$20.1M-50.1% | -$20.01M-74.6% | ||
| -$25.27M-24.6% | -$19.15M-6.1% | -$18.25M+9.9% | -$20.37M-49.2% | -$20.28M-72.9% |
FAQ
- What is Pulse Biosciences, Inc.'s revenue?
- Pulse Biosciences, Inc. (PLSE) generated $1.2M in revenue over the trailing twelve months.
- Is Pulse Biosciences, Inc. profitable?
- Pulse Biosciences, Inc. is not currently profitable: it reported a net loss of $80.1M over the trailing twelve months, a -6755.8% net margin.
- What are Pulse Biosciences, Inc.'s profit margins?
- Gross margin is -0.1% and operating margin is -7007.8%, with a -6755.8% net margin.
- Where does Pulse Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
